The Technical University of Munich is a public research university in Munich, with additional campuses in Garching, Freising, Heilbronn, Straubing, and Singapore.

During the past decade, Technische Universität München conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 7 clinical trials were completed, i.e. on average, 24.1% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 2 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Technische Universität München" #1 sponsor was "Technical University of Munich" with 13 trials, followed by "Pfizer" with 4 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 2 trials sponsored, "Heidelberg University" with 2 trials sponsored and "Ludwig-Maximilians - University of Munich" with 2 trials sponsored. Other sponsors include 46 different institutions and companies that sponsored additional 54 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Technische Universität München" #1 collaborator was "Technical University of Munich" with 9 trials as a collaborator, "Heidelberg University" with 3 trials as a collaborator, "German Research Foundation" with 2 trials as a collaborator, "Ludwig-Maximilians - University of Munich" with 2 trials as a collaborator and "Roche Pharma AG" with 2 trials as a collaborator. Other collaborators include 59 different institutions and companies that were collaborators in the rest 66 trials.

According to Clinical.Site data, the most researched conditions in "Technische Universität München" are "Psoriasis" (4 trials), "Healthy" (3 trials), "Huntington's Disease" (3 trials), "Alzheimer Disease" (2 trials) and "Breast Cancer" (2 trials). Many other conditions were trialed in "Technische Universität München" in a lesser frequency.

Most popular intervention types in "Technische Universität München" are "Drug" (29 trials), "Procedure" (13 trials), "Device" (10 trials), "Other" (8 trials) and "Behavioral" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Capnography" (4 trials), "Guselkumab" (2 trials), "Secukinumab" (2 trials) and "Standard monitoring" (2 trials). Other intervention names were less common.

The vast majority of trials in "Technische Universität München" are 66 trials for "All" genders, 6 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Technische Universität München". 1 are not yet recruiting, 12 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 38 completed trials in Technische Universität München, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Technische Universität München, 4 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 17 trials that are defined as “Not Applicable".